Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03933878 · ClinicalTrials.gov registry record

Rapid Detection of Airway Pathogens for Lung Transplantation

A clinical trial of Respiratory Tract Infections and Lung Transplantation, sponsored by University of California, San Francisco.

Completed
Registry status
200
Enrollment target
1
Study location

NCT03933878: Completed study of Respiratory Tract Infections and Lung Transplantation, sponsored by University of California, San Francisco.

NCT03933878 is a study of Respiratory Tract Infections and Lung Transplantation that has completed, run by University of California, San Francisco. The registered enrollment target is 200 participants, below the 2,761-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03933878, a study of Respiratory Tract Infections and Lung Transplantation, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Pneumonias and lower respiratory tract infections can have important long-term consequences, particularly in the context of lung transplantation, where pneumonia is a major cause of death. Candidate organs and lung transplant recipients undergo bronchoscopic inspection to assess for lower respiratory tract infection, but traditional culture methods take time, leading to increased risk from inappropriate therapy. The investigators hypothesize that the rapid detection of lower respiratory tract infection, using a semi-quantitative multiplex molecular assay, can decrease the time to appropriate clinical decision making.

Primary Outcome

The investigators will measure the difference between the time that microbiology results became available using standard of care diagnostics and the time of result from molecular methods.

Study Locations (1)

California

  • UCSF Parnassus - San Francisco

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-03-19
Est. Completion 2021-03-05

What the finished NCT03933878 record still lists

NCT03933878 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,761-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Respiratory Tract Infections appearing as the primary indexed condition, and to 0 interventions.

NCT03933878 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03933878 about?

NCT03933878 is a clinical study titled "Rapid Detection of Airway Pathogens for Lung Transplantation". Pneumonias and lower respiratory tract infections can have important long-term consequences, particularly in the context of lung transplantation, where pneumonia is a major cause of death. Candidate organs and lung transplant recipients undergo bronchoscopic inspection to assess for lower respirator...

What is the current status of trial NCT03933878?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-03-19. Estimated completion is 2021-03-05.

What conditions does trial NCT03933878 study?

This clinical trial studies the following conditions: Respiratory Tract Infections, Lung Transplantation, Pulmonary Infection.

Who is sponsoring clinical trial NCT03933878?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03933878 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Tract Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03933878's enrollment target sits among peer trials

200 9th of 15 higher than 7 of 15 other Respiratory Tract Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03933878, the US trial registry maintained by the National Library of Medicine. NCT03933878 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.